AMSTERDAM , July 23, 2014 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") reported second quarter 2014 GAAP earnings per diluted share ("EPS") of $1.42 , and second quarter EPS of $1.35 , when excluding foreign exchange translations ("ex-fx") and normalizing for a 24% effective tax rate (both referred to as "ex-items"), both setting second quarter records.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.